颅外段颈部动脉粥样硬化性疾病外科治疗京津冀专家共识  

Beijing-Tianjin-Hebei expert consensus on the surgical treatment of extracranial segmental carotid atherosclerotic disease

作　　者：无 杨新宇 王涛[3] 赵宗茂 赵岩 林云鹏 

机构地区：[1]天津市医学会神经外科学分会 [2]天津医科大学总医院 [3]北京大学第三医院 [4]河北医科大学第四医院

出　　处：《天津医药》2024年第3期225-230,共6页Tianjin Medical Journal

摘　　要：颅外段颈部动脉粥样硬化性疾病是最常见的脑血管病类型,外科治疗是降低患者致残率和死亡率的重要手段。天津市医学会神经外科学分会牵头组织京津冀专家结合近年来我国的临床实践和国内外相关的循证医学证据,制订了该共识。该共识对颅外段颈部动脉粥样硬化性疾病危险人群的筛查、危险因素控制、外科治疗方案以及围手术期管理等进行了总结,旨在为我国颈部动脉粥样硬化性疾病的临床治疗提供循证的规范性指导。Extracranial segmental carotid atherosclerotic disease is the most common type of cerebrovascular disease,and surgical treatment is an important means to reduce disability and mortality of patients.The Neurosurgery Branch of Tianjin Medical Association led the organization of Beijing-Tianjin-Hebei experts to develop this consensus by combining the clinical practice in China in recent years and relevant evidence-based medical evidence at home and abroad.The consensus summarizes the screening of the risk group of extracranial segmental carotid atherosclerotic disease,risk factor control,surgical treatment options,and perioperative management,aiming to provide evidence-based normative guidance for the clinical treatment of carotid atherosclerotic disease in China.

关 键 词：动脉粥样硬化 颈动脉狭窄 椎底动脉供血不足 锁骨下动脉窃血综合征 

分 类 号：R651.12[医药卫生—外科学]